Annals of Clinical and Translational Neurology (Sep 2022)

GGPS1‐associated muscular dystrophy with and without hearing loss

  • Rauan Kaiyrzhanov,
  • Luke Perry,
  • Clarissa Rocca,
  • Maha S. Zaki,
  • Heba Hosny,
  • Cristiane Araujo Martins Moreno,
  • Rahul Phadke,
  • Irina Zaharieva,
  • Clara Camelo Gontijo,
  • Christian Beetz,
  • Veronica Pini,
  • Mojtaba Movahedinia,
  • Edmar Zanoteli,
  • Stephanie DiTroia,
  • Sandrine Vuillaumier‐Barrot,
  • Arnaud Isapof,
  • Mohammad Yahya Vahidi Mehrjardi,
  • Nasrin Ghasemi,
  • Anna Sarkozy,
  • Francesco Muntoni,
  • Sandra Whalen,
  • Barbara Vona,
  • Henry Houlden,
  • Reza Maroofian

DOI
https://doi.org/10.1002/acn3.51633
Journal volume & issue
Vol. 9, no. 9
pp. 1465 – 1474

Abstract

Read online

Abstract Ultra‐rare biallelic pathogenic variants in geranylgeranyl diphosphate synthase 1 (GGPS1) have recently been associated with muscular dystrophy/hearing loss/ovarian insufficiency syndrome. Here, we describe 11 affected individuals from four unpublished families with ultra‐rare missense variants in GGPS1 and provide follow‐up details from a previously reported family. Our cohort replicated most of the previously described clinical features of GGPS1 deficiency; however, hearing loss was present in only 46% of the individuals. This report consolidates the disease‐causing role of biallelic variants in GGPS1 and demonstrates that hearing loss and ovarian insufficiency might be a variable feature of the GGPS1‐associated muscular dystrophy.